About SIENI HOLDINGS
AEGEAL, developed by SIENI Holdings, is a first-in-class platform for localized, controlled, and sustained treatment of musculoskeletal conditions using FDA-approved drugs. It is designed for both surgical and non-surgical applications, offering benefits such as faster healing and reduced systemic exposure.
Localized, sustained drug delivery using injectable gel platformControlled release of FDA-approved drugs for musculoskeletal conditionsTreatment of inflammation, infection, pain, and post-surgical complicationsAdaptable across orthopedic, trauma, burn, and veterinary applicationsSustained and programmable release (3-14 days)Multimodal action with 1+ APIs of proven efficacy
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SIENI HOLDINGS right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.